EyePoint Pharmaceuticals, Inc. Financial Ratios — EYPT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-19.15	-73.36	-64.59	-68.63	23.06	-67.35	-73.5	-117.7	-78.53	-55.13	-32.9	-46.09	-26.44	-33.83	-59.29
Return on Capital (%)	- -	- -	- -	- -	-2.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	33.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	86.81	83.09	77.86	79.89	89.93	91.42	93.41
EBITDA Margin (%)	-133.9	-231.25	-515.03	-364.27	27.49	-1,288.02	-235.59	-848.56	-222.23	-100.59	-142.14	-184.75	-162.12	-333.5	-768.62
Operating Margin (%)	-201.47	-294.41	-561.41	-390.67	24.17	-1,344.07	-246.4	-887.34	-235.02	-108.28	-149.64	-190.65	-163.13	-337.06	-775.98
Incremental Operating Margin (%)	- -	- -	- -	- -	86.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-178.17	-709.13	-560.76	-388.28	24.25	-1,339.63	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.66	-302.22	-738.53
Profit Margin (%)	-173.78	-704.34	-555.3	-384.54	23.89	-1,330.06	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.84	-302.43	-739.42
Net Income to Common Margin (%)	-173.78	-704.34	-555.3	-384.54	23.89	-1,330.06	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.84	-302.43	-739.42
Effective Tax Rate (%)	- -	- -	- -	- -	1.49	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	17	51	41	39	46	5	22	21
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	10	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	17	50	40	38	35	5	22	21
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.69	-1.12	-1.18	-0.75	-0.6	-0.07	-0.15	-0.09
Net Debt/EBITDA	1.94	0.57	0.63	1.21	-2.62	0.73	0.95	0.85	-0.55	0.2	2.71	0.73	3.77	0.69	0.42
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.66	-1.06	-1.1	-0.71	-0.58	-0.07	-0.15	-0.09
Net Debt/EBIT	1.29	0.45	0.57	1.13	-2.98	0.7	0.91	0.82	-0.52	0.19	2.57	0.71	3.75	0.68	0.42
EBITDA to Interest Expense	-511.38	-8,154	-5,518.5	-12,651	- -	- -	- -	-34.9	-7.33	-4.77	-9.55	-23.99	-59.83	-10,308.14	-7,306.82
EBITDA-CapEx/Interest Expense	-521.62	-8,559	-5,552.5	-12,899	- -	- -	- -	-35.05	-7.36	-4.82	-9.58	-24.66	-62.62	-10,597.57	-7,406.21
EBIT to Interest Expense	-769.46	-10,381	-6,015.5	-13,568	- -	- -	- -	-36.49	-7.75	-5.14	-10.05	-24.75	-60.2	-10,418.14	-7,376.79
Interest Expense	- -	- -	- -	- -	- -	- -	- -	1	6	7	5	3	1	- -	- -
Common Equity/Total Assets	-481.61	-1,222.2	-1,622.47	-1,221.75	-836.15	-924.06	-1,663.98	-507.77	-637.62	-556.78	-216.07	-372.22	-208.93	-208.61	-303.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	601.69	217.39	20.84	36.62	1.84	6.5	6.79
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.99	-12.09	-8.58	-7.25	-5.64	-0.67	-2.57	-1.92
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	68.69	43.95	14.59	19.57	1.38	5.22	5.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	607.47	221.1	21.26	47.49	1.84	6.5	6.79
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.99	-12.2	-8.73	-7.4	-7.32	-0.67	-2.57	-1.92
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	69.35	44.7	14.89	25.38	1.38	5.22	5.71
Net Debt to Equity	-34.49	-33.92	-89.6	-102.75	-81.83	-73.33	-126.71	-183.68	300.23	-37.39	-77.03	-57.95	-105.61	-29.63	-33.26
Net Debt/Capital (%)	5.38	1.8	2.55	5.25	6.6	4.98	5.16	5.57	-5.72	1.35	20.05	7.74	27.62	10.49	8.59
EBITDA	-7	-8	-11	-13	7	-21	-18	-25	-45	-35	-53	-76	-75	-144	-241
EBITDA-CapEx	-7	-9	-11	-13	7	-21	-18	-25	-45	-35	-53	-79	-78	-148	-244
Operating Income (Loss)	-10	-10	-12	-14	6	-22	-19	-26	-48	-37	-55	-79	-75	-146	-243

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.79	4.58	3.11	8.6	8.52	5.69	3.19	1.79	1.93	3.02	8.94	4.19	5.23	7.56	8.27
Current Ratio	5.04	5.02	3.77	9.1	8.91	5.88	3.35	1.84	3.62	4.24	10.05	5	5.45	7.81	8.88
Quick Ratio	4.96	4.89	3.29	8.84	8.71	5.79	3.24	1.81	2.92	3.65	9.72	4.63	5.25	7.57	8.28
CFO/Avg Current Liab	-0.8	-2.19	-2.7	-3.93	3.76	-3.87	-3.95	-1.63	-3.42	-1.09	-2.6	-2.23	0.04	-2.25	-5.58
Common Equity/Total Assets	-481.61	-1,222.2	-1,622.47	-1,221.75	-836.15	-924.06	-1,663.98	-507.77	-637.62	-556.78	-216.07	-372.22	-208.93	-208.61	-303.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	601.69	217.39	20.84	36.62	1.84	6.5	6.79
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.99	-12.09	-8.58	-7.25	-5.64	-0.67	-2.57	-1.92
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	68.69	43.95	14.59	19.57	1.38	5.22	5.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	607.47	221.1	21.26	47.49	1.84	6.5	6.79
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.99	-12.2	-8.73	-7.4	-7.32	-0.67	-2.57	-1.92
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	69.35	44.7	14.89	25.38	1.38	5.22	5.71
CFO/Total Liabilities	-32.75	-129.31	-102.29	-137.74	114.42	-151.95	-383.64	-36.52	-87.71	-19.73	-63.42	-77.4	2.11	-154	-414.82
CFO/CapEx	-23.83	-22.22	-128.6	-43.03	63.96	-144.39	-139.39	-202.84	-266.19	-39.88	-321.13	-30.23	0.54	-31.15	-73.2
Altman's Z-Score	-7.41	-18.33	-24.61	-11.29	-2.45	-9.73	-19.09	-13.21	-15.12	-10.52	-0.17	-4.57	3.53	0.06	8.46

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.08	3.9	2.74	6.24	46.65	2.92	20.4	9.8	3.47	3.31	2.66	2.45	5.64	61.29	49.87
Days Sales Outstanding	71.82	93.68	133.19	58.54	7.82	125.05	17.89	37.23	105.04	110.34	137.38	149.23	64.67	5.95	7.32
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	2.51	1.56	1.83	2.56	1.36	1.2	1
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	145.21	234.24	199.82	142.52	267.6	305.36	363.76
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	1.35	2	1.06	1.14	0.91	0.23	0.14
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	269.76	182.1	344.76	319.64	401.13	1,575.59	2,575.29
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-19.51	162.48	-7.56	-27.89	-68.85	-1,264.27	-2,204.21
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	-40.17	-123.89	-62.44	6.72	-202.93	-299.41	-356.44
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	5	4	3	4	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	3	3	1	1	2	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	1	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	2	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	83	48	89	119	111	89	60	96	162	84	352	131	899	419	1,338
- Cash & Cash Equivalents	13	5	7	15	19	15	17	39	22	45	179	96	281	100	102
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	17	51	41	39	46	5	22	21
Enterprise Value	59	33	79	101	82	61	44	75	190	81	180	32	573	70	1,053
Total Capital	-227	-252	-264	-277	-271	-292	-311	-347	-415	-470	-530	-626	-737	-851	-1,084
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.99	-12.2	-8.73	-7.4	-7.32	-0.67	-2.57	-1.92
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.23	0.27	0.51	0.22	1.44	0.01	0.31	0.02
EV/Sales	11.94	9.49	36.82	29.03	3.1	37.35	5.78	25.22	9.33	2.34	4.86	0.77	12.45	1.63	33.57
EV/EBITDA	- -	- -	- -	- -	11.26	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	12.8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	7.98	- -	- -	- -	- -	- -	- -	- -	183.43	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	7.86	- -	- -	- -	- -	- -	- -	- -	86.72	- -	- -
Diluted Market Cap	83	48	89	119	115	89	60	96	162	84	352	131	899	419	1,338
Diluted Enterprise Value	71	43	82	104	96	74	44	75	190	81	213	81	623	342	1,257
EV per Share	30.42	16.09	34.24	36.74	27.99	19.13	12.32	16.16	18.22	6.27	6.25	0.85	14.73	1.25	14.37
TTM Sales	5	4	2	3	27	2	8	3	20	34	37	41	46	43	31
TTM EBITDA	-7	-8	-11	-13	7	-21	-18	-25	-45	-35	-53	-76	-75	-144	-241
TTM Operating Income	-10	-10	-12	-14	6	-22	-19	-26	-48	-37	-55	-79	-75	-146	-243
TTM Cash Flow to Firm	-3	-9	-9	-11	10	-16	-20	-21	-51	-7	-45	-62	3	-126	-240
TTM Free Cash Flow to Firm	-3	-9	-9	-10	10	-16	-20	-21	-50	-7	-44	-60	7	-122	-237

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-27.47	-5.59	-10.28	-11.43	11.03	-5.52	-2.97	-4.41	-2.86	-6	-7.05	-2.08	167.8	-3.43	-5.65
EV/EBIT	- -	- -	- -	- -	12.8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	59	33	79	101	82	61	44	75	190	81	180	32	573	70	1,053
Low Price	31.6	10.2	11.7	22.8	34.5	23.7	15	9.3	11.9	3.5	6.87	2.19	2.21	6.9	3.91
EV/Sales	11.94	9.49	36.82	29.03	3.1	37.35	5.78	25.22	9.33	2.34	4.86	0.77	12.45	1.63	33.57
EV/EBITDA	- -	- -	- -	- -	11.26	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	17.45	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-9.88	-2.24	-3.92	-7.74	19.3	-5.16	-4.48	-1.22	-3.38	-2.42	-5.4	-3.16	-4.38	-6.06	-3.15
Price/Earnings High	-16.31	-4.38	-7.8	-11.51	22.87	-8.53	-8.13	-2.5	-5.18	-5.94	-10.58	-5.26	-13.53	-13.33	-6.03
Price/Earnings Low	-7.14	-0.85	-2.27	-4.69	15.97	-3.48	-2.87	-0.81	-2.19	-0.99	-3.38	-0.8	-1.21	-2.97	-1.23
Price/Book Value	-0.37	-0.19	-0.34	-0.43	-0.41	-0.31	-0.19	-0.26	-0.35	-0.17	-0.62	-0.19	-1.21	-0.48	-1.21
Price/Book Value Average	-0.38	-0.22	-0.18	-0.37	-0.45	-0.38	-0.27	-0.18	-0.41	-0.21	-0.55	-0.48	-0.42	-0.91	-0.66
Price/Book Value High	-0.62	-0.43	-0.35	-0.55	-0.54	-0.63	-0.48	-0.37	-0.63	-0.53	-1.09	-0.8	-1.29	-2	-1.27
Price/Book Value Low	-0.27	-0.08	-0.1	-0.23	-0.37	-0.26	-0.17	-0.12	-0.27	-0.09	-0.35	-0.12	-0.12	-0.44	-0.26
Price/Tangible Book Value	5.26	5.1	20.89	9.8	5.17	4.52	4.66	-4.89	-8.36	-12.67	2.18	1.36	3.38	1.25	4.37
Price/Tangible Book Value Average	5.37	5.91	10.92	8.51	5.71	5.62	6.38	-3.28	-9.93	-16.45	1.95	3.36	1.17	2.36	2.39
Price/Tangible Book Value High	8.87	11.56	21.75	12.64	6.77	9.29	11.58	-6.77	-15.21	-40.43	3.83	5.58	3.6	5.18	4.57
Price/Tangible Book Value Low	3.88	2.25	6.31	5.15	4.73	3.79	4.09	-2.19	-6.42	-6.74	1.22	0.85	0.32	1.15	0.94
Price/Sales	16.8	13.62	41.61	34.3	4.17	55.24	8.02	32.47	7.94	2.45	9.53	3.15	19.54	9.69	42.66
Price/Sales Average	17.16	15.78	21.75	29.78	4.61	68.64	10.97	21.82	9.43	3.19	8.54	7.81	6.75	18.32	23.27
Price/Sales High	28.34	30.84	43.34	44.25	5.46	113.41	19.92	44.96	14.44	7.83	16.74	12.99	20.81	40.32	44.62
Price/Sales Low	12.4	6.01	12.58	18.02	3.82	46.26	7.03	14.52	6.1	1.3	5.35	1.97	1.87	8.98	9.13
Price/Cash Flow	-26.31	-5.34	-10.2	-11.16	10.76	-5.48	-2.95	-4.39	-2.85	-5.85	-7.03	-2.01	479.5	-3.32	-5.57
Price/Cash Flow Average	-26.88	-6.18	-5.33	-9.69	11.9	-6.81	-4.04	-2.95	-3.39	-7.6	-6.29	-4.98	165.56	-6.28	-3.04
Price/Cash Flow High	-44.39	-12.08	-10.62	-14.4	14.09	-11.26	-7.33	-6.08	-5.19	-18.67	-12.34	-8.27	510.84	-13.82	-5.83
Price/Cash Flow Low	-19.43	-2.36	-3.08	-5.86	9.84	-4.59	-2.59	-1.96	-2.19	-3.11	-3.94	-1.26	45.85	-3.08	-1.19
Price/Free Cash Flow Average	-28.06	-6.47	-5.37	-9.92	12.2	-6.86	-4.07	-2.96	-3.4	-7.8	-6.31	-5.15	57.94	-6.49	-3.08
Price/Free Cash Flow High	-46.33	-12.65	-10.7	-14.74	14.45	-11.34	-7.38	-6.11	-5.21	-19.15	-12.38	-8.56	178.76	-14.28	-5.91
Price/Free Cash Flow Low	-20.28	-2.47	-3.11	-6	10.09	-4.63	-2.61	-1.97	-2.2	-3.19	-3.96	-1.3	16.05	-3.18	-1.21
EV/Sales Average	14.56	14.47	18.54	25.36	3.89	59.18	8.73	14.57	10.83	3.07	4.76	6.61	0.74	16.52	20.69
EV/Sales High	25.74	29.53	40.12	39.84	4.74	103.96	17.68	37.71	15.84	7.71	12.96	11.78	14.81	38.52	42.04
EV/Sales Low	9.8	4.7	9.36	13.6	3.1	36.81	4.79	7.27	7.49	1.19	1.57	0.77	- -	7.18	6.55
EV/EBITDA Average	-10.88	-6.26	-3.6	-6.96	14.16	-4.59	-3.71	-1.72	-4.87	-3.05	-3.35	-3.58	-0.46	-4.95	-2.69
EV/EBITDA High	-19.22	-12.77	-7.79	-10.94	17.25	-8.07	-7.51	-4.44	-7.13	-7.67	-9.12	-6.38	-9.13	-11.55	-5.47
EV/EBITDA Low	-7.32	-2.03	-1.82	-3.73	11.26	-2.86	-2.03	-0.86	-3.37	-1.18	-1.11	-0.42	2.55	-2.15	-0.85
EV/EBIT Average	-7.23	-4.91	-3.3	-6.49	16.1	-4.4	-3.54	-1.64	-4.61	-2.84	-3.18	-3.47	-0.45	-4.9	-2.67
EV/EBIT High	-12.78	-10.03	-7.15	-10.2	19.62	-7.73	-7.18	-4.25	-6.74	-7.12	-8.66	-6.18	-9.08	-11.43	-5.42
EV/EBIT Low	-4.87	-1.6	-1.67	-3.48	12.81	-2.74	-1.94	-0.82	-3.19	-1.1	-1.05	-0.4	2.54	-2.13	-0.84
Last Price	42.8	23.1	38.7	43.4	37.7	28.3	17.1	20.8	15.5	6.58	12.24	3.5	23.11	7.45	18.27
High Price	72.2	52.3	40.3	56	49.4	58.1	42.5	28.8	28.2	21	21.5	14.41	24.62	30.99	19.11
Enterprise Value Average	72	51	40	88	103	96	66	43	221	106	176	274	34	715	649
Enterprise Value High	128	104	86	138	126	168	133	112	323	266	479	488	681	1,667	1,319
Enterprise Value Low	49	17	20	47	82	60	36	22	153	41	58	32	-190	311	205

Shares Outstanding	2	2	2	3	3	3	4	7	11	18	34	34	49	68	83
Diluted Weighted Avg Shares	2	2	2	3	3	3	4	5	10	13	29	37	39	56	73
Basic Weighted Avg Shares	2	2	2	3	3	3	4	5	10	13	29	37	39	56	73
Revenue per Share	2.55	1.7	0.93	1.27	9.04	0.51	2.13	0.64	1.95	2.68	1.28	1.11	1.18	0.77	0.43
EBITDA per Share	-3.41	-3.92	-4.79	-4.61	2.49	-6.6	-5.03	-5.44	-4.34	-2.7	-1.83	-2.05	-1.92	-2.56	-3.29
Operating Income per Share	-5.13	-4.99	-5.22	-4.94	2.19	-6.89	-5.26	-5.68	-4.59	-2.91	-1.92	-2.12	-1.93	-2.59	-3.32
Basic EPS, GAAP	-4.43	-11.95	-5.16	-4.87	2.16	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Basic EPS from Cont Ops	-4.43	-11.95	-5.16	-4.87	2.16	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Diluted EPS, GAAP	-4.43	-11.95	-5.16	-4.87	2.08	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Diluted EPS from Cont Ops	-4.43	-11.95	-5.16	-4.87	2.08	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.63	-4.33	-3.79	-3.89	3.51	-5.16	-5.8	-4.74	-5.44	-1.12	-1.74	-1.74	0.05	-2.24	-3.28
Free Cash Flow per Basic Share	-1.69	-4.52	-3.82	-3.98	3.45	-5.2	-5.84	-4.76	-5.46	-1.15	-1.75	-1.8	-0.04	-2.31	-3.32
Cash & Equivalents per Share	12.38	7.01	4.46	6.66	9.71	9.17	4.78	8.39	2.13	3.5	7.36	3.87	8.51	6.59	4.18
Book Value per Share	-116.43	-121.08	-114.41	-100.93	-92.12	-92.39	-87.93	-78.73	-44.61	-39.78	-19.79	-17.99	-19.08	-15.51	-15.08
Tangible Book Value per Share	8.14	4.53	1.85	4.43	7.3	6.25	3.67	-4.26	-1.85	-0.52	5.62	2.58	6.85	5.98	4.18

EyePoint Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)